Biostem Technologies S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OID
BioStem Technologies files an S-1/A amendment detailing a significant revenue decrease in Q1 2026 compared to the prior year, alongside a net loss, while also outlining strategic acquisitions and future growth plans.
OID
BioStem Technologies, Inc. has filed an S-1 registration statement to allow a selling stockholder to resell up to 3,571,429 shares of common stock.